Thomas O. Schrader

Expression of Endothelin-1, Endothelin-Converting Enzyme, and Endothelin Receptors in Chronic Heart Failure

Oliver Zolk, Jessika Quattek, G. Sitzler et al. · Circulation · 1999 · 190 citations

3-(1<i>H</i>-Tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): A Partial Agonist of the Nicotinic Acid Receptor, G-Protein Coupled Receptor 109a, with Antilipolytic but No Vasodilatory Activity in Mice

Graeme Semple, Philip J. Skinner, Tawfik Gharbaoui et al. · Journal of Medicinal Chemistry · 2008 · 93 citations · Full text

No Vasodilatory Activity, Hyperlipidemia, Pharmacotherapy +21

(PCy3)2Cl2RuCHPh Catalyzed Kharasch additions. Application in a formal olefin carbonylation

Belinda T. Lee, Thomas O. Schrader, Belén Martı́n-Matute et al. · Tetrahedron · 2004 · 58 citations

Stereodivergent Synthesis of All 15-F₂ Isoprostanes

Thomas O. Schrader, Marc L. Snapper · Journal of the American Chemical Society · 2002 · 54 citations

Secondary Metabolite, Organic Chemistry, Chemistry +16

(1a<i>R</i>,5a<i>R</i>)1a,3,5,5a-Tetrahydro-1<i>H</i>-2,3-diaza-cyclopropa[<i>a</i>]pentalene-4-carboxylic Acid (MK-1903): A Potent GPR109a Agonist that Lowers Free Fatty Acids in Humans

P. Douglas Boatman, Brett Lauring, Thomas O. Schrader et al. · Journal of Medicinal Chemistry · 2012 · 50 citations · Full text

Pharmacotherapy, Pharmaceutical Chemistry, Molecular Pharmacology +17